Variant report
Variant | esv3339257 |
---|---|
Chromosome Location | chr6:72163131-72166329 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538161745 | chr6:72163163-72163164 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550410795 | chr6:72163195-72163196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188957743 | chr6:72163200-72163201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs193152103 | chr6:72163216-72163217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185258167 | chr6:72163252-72163253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147373855 | chr6:72163262-72163263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138048345 | chr6:72163300-72163301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533837622 | chr6:72163303-72163304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558808241 | chr6:72163316-72163317 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs370407336 | chr6:72163349-72163350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544187671 | chr6:72163387-72163388 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs562791124 | chr6:72163468-72163469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs574785309 | chr6:72163470-72163471 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555568394 | chr6:72163501-72163502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541797775 | chr6:72163574-72163575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs189835286 | chr6:72163575-72163576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560244876 | chr6:72163591-72163592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527805596 | chr6:72163664-72163665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs574023412 | chr6:72163668-72163669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs181615050 | chr6:72163677-72163678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184057611 | chr6:72163699-72163700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531926702 | chr6:72163768-72163769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149508927 | chr6:72163776-72163777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568716354 | chr6:72163807-72163808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs560468567 | chr6:72163855-72163856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201206278 | chr6:72163871-72163872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs852943 | chr6:72163964-72163965 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs71538490 | chr6:72163988-72163989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200268333 | chr6:72163990-72163991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs116206558 | chr6:72163991-72163992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114069844 | chr6:72163992-72163993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs35418536 | chr6:72163994-72163995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533875877 | chr6:72164006-72164007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558579421 | chr6:72164021-72164022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188743620 | chr6:72164032-72164033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528805485 | chr6:72164044-72164045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76449321 | chr6:72164202-72164203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556209309 | chr6:72164271-72164272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371192029 | chr6:72164302-72164303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574657877 | chr6:72164343-72164344 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541695702 | chr6:72164376-72164377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs852944 | chr6:72164390-72164391 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs572070094 | chr6:72164426-72164427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546343137 | chr6:72164442-72164443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs34326827 | chr6:72164446-72164447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144185450 | chr6:72164475-72164476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs58258982 | chr6:72164479-72164480 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs6938591 | chr6:72164553-72164554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561626517 | chr6:72164590-72164591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs80011236 | chr6:72164595-72164596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ovarian cancer | 17437010 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Breast cancer | 20409316 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:72156000-72167400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr6:72162200-72163400 | Enhancers | Fetal Lung | lung |
3 | chr6:72162400-72163200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:72162400-72163200 | Enhancers | Fetal Brain Female | brain |
5 | chr6:72162400-72163200 | Enhancers | Fetal Stomach | stomach |
6 | chr6:72162600-72163400 | Enhancers | Rectal Smooth Muscle | rectum |
7 | chr6:72162600-72167400 | Weak transcription | HSMMtube | muscle |
8 | chr6:72162800-72170400 | Weak transcription | NHDF-Ad | bronchial |